1-1 of 1
Avriti Baveja, MD
Close
Sort by
Journal Articles

Early Molecular Response with Generic Imatinib Therapy in Sokal/Hasford Intermediate- & High-Risk Chronic Phase Chronic Myeloid Leukemia Patients: A Single Institution Experience from India

Uttam Kumar Nath, MDDM, Rituparna Chetia, MD, Avriti Baveja, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4276.
https://doi.org/10.1182/blood-2018-99-110523
Published: 2018